Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mills

Showing results (721-730 of 888) with videos related to

Pageof 89
Sort By:
Molecular Cancer Research : MCR|March 18, 2022
Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate CancersPamela J Maxwell, Melanie McKechnie, Christopher W Armstrong, et al.
Neuropharmacology|March 23, 2000
The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferretsF D Tattersall, W Rycroft, M Cumberbatch, et al.
European Heart Journal|May 17, 2013
Clinical outcomes after myocardial revascularization according to operator training status: cohort study of 22,697 patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgeryDaniel A Jones, Sean Gallagher, Krishnaraj Rathod, et al.
Msphere|May 16, 2025
Highlights of the 14th International <i>Bordetella</i> SymposiumKevin Munoz Navarrete, Kathryn M Edwards, Kingston H G Mills, et al.
BMC Cancer|October 14, 2021
The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancerR Martino, M I Fitch, C D Fuller, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptorsLin Yan, Jeffrey J Hale, Christopher L Lynch, et al.
Chemical Research in Toxicology|December 3, 2019
Toward Less Hazardous Industrial Compounds: Coupling Quantum Mechanical Computations, Biomarker Responses, and Behavioral Profiles To Identify Bioactivity of S<sub>N</sub>2 Electrophiles in Alternative Vertebrate ModelsW Baylor Steele, Lauren A Kristofco, Jone Corrales, et al.
Cell Reports|April 5, 2023
PYHIN protein IFI207 regulates cytokine transcription and IRF7 and contributes to the establishment of K. pneumoniae infectionMarcin Baran, Claudia Feriotti, Aoife McGinley, et al.
BMC Infectious Diseases|August 17, 2022
Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018)Sirigade Ruekit, Apichai Srijan, Oralak Serichantalergs, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
Pageof 89

Showing results (721-730 of 888) with videos related to

Sort By:
Pageof 89
Molecular Cancer Research : MCR|March 18, 2022
Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate CancersPamela J Maxwell, Melanie McKechnie, Christopher W Armstrong, et al.
Neuropharmacology|March 23, 2000
The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferretsF D Tattersall, W Rycroft, M Cumberbatch, et al.
European Heart Journal|May 17, 2013
Clinical outcomes after myocardial revascularization according to operator training status: cohort study of 22,697 patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgeryDaniel A Jones, Sean Gallagher, Krishnaraj Rathod, et al.
Msphere|May 16, 2025
Highlights of the 14th International <i>Bordetella</i> SymposiumKevin Munoz Navarrete, Kathryn M Edwards, Kingston H G Mills, et al.
BMC Cancer|October 14, 2021
The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancerR Martino, M I Fitch, C D Fuller, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptorsLin Yan, Jeffrey J Hale, Christopher L Lynch, et al.
Chemical Research in Toxicology|December 3, 2019
Toward Less Hazardous Industrial Compounds: Coupling Quantum Mechanical Computations, Biomarker Responses, and Behavioral Profiles To Identify Bioactivity of S<sub>N</sub>2 Electrophiles in Alternative Vertebrate ModelsW Baylor Steele, Lauren A Kristofco, Jone Corrales, et al.
Cell Reports|April 5, 2023
PYHIN protein IFI207 regulates cytokine transcription and IRF7 and contributes to the establishment of K. pneumoniae infectionMarcin Baran, Claudia Feriotti, Aoife McGinley, et al.
BMC Infectious Diseases|August 17, 2022
Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018)Sirigade Ruekit, Apichai Srijan, Oralak Serichantalergs, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
Pageof 89